akhatri

Class 4 Medicines Defect Information: Zoledronic Acid Ennogen 4mg/5ml concentrate for solution for infusion (Ennogen Healthcare Limited) Drug alert number: EL (24)A/53 Date issued: 07 November 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Zoledronic Acid Ennogen 4mg/5ml concentrate for solution for infusion (Ennogen [...]

The post MHRA Class 4 Medicines Defect Information: Zoledronic Acid Ennogen 4mg/5ml concentrate for solution for infusion (Ennogen Healthcare Limited) appeared first on Community Pharmacy England.

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 18 Issue 4 November 2024) has been published and includes articles on: MedSafetyWeek November 2024: your Yellow Card report helps prevent future harm to others and improves patient safety Letters and medicine recalls sent to healthcare professionals in October 2024 To see the [...]

The post MHRA Drug Safety Update: November 2024 appeared first on Community Pharmacy England.

The NHS Business Services Authority (NHSBSA) host webinars to provide an insight into how they process and reimburse prescriptions. These sessions take place online and last approximately 60 minutes. During the sessions, pharmacy teams are shown how NHSBSA handle prescription submissions and are given an overview of the most common errors found on prescriptions submitted [...]

The post NHSBSA Online Webinars for Pharmacy Teams appeared first on Community Pharmacy England.

Update 31/10/204 – This recall notification has been updated since its initial publication on 29 October 2024 to include the correct description for Labetalol 200mg Tablets. Tillomed Laboratories Limited erroneously provided incorrect information pertaining the description and have ensured that all other information is correct. Please ensure that appropriate action is taken. Drug alert number: [...]

The post MHRA Class 2 Medicines Recall: Labetalol 200mg Tablets (Tillomed Laboratories Limited) – Update appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Information: Paracetamol 500mg Effervescent Tablets (Kent Pharma UK) Drug alert number: EL(24)A/49 Date issued: 21 October 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Paracetamol 500mg Effervescent Tablets (Kent Pharma UK) Company name: Kent Pharma UK Product name: Paracetamol [...]

The post MHRA Class 4 Medicines Defect Information: Paracetamol 500mg Effervescent Tablets (Kent Pharma UK) appeared first on Community Pharmacy England.